Ginkgo Bioworks Raises $350M in Series E

Ginkgo Bioworks has successfully raised $350M in a Series E at a $4.9B valuation led by Baillie Gifford, General Atlantic, Cascade Investment, T. Rowe Price, Viking Global Investors.

Company Overview

Ginkgo Bioworks is a Biotech company headquartered in 27 Drydock Avenue, Boston, MA 02210, founded in 2008 with 700+ employees.

Organism engineering platform

Fundraising Details

Amount Raised: $350M
Round Type: Series E
Valuation: $4.9B
Date: 2024-11-11
Investors: Baillie Gifford, General Atlantic, Cascade Investment, T. Rowe Price, Viking Global Investors

About Ginkgo Bioworks

Organism engineering platform The company is positioned in the Biotech sector, serving a growing market with innovative solutions.

Key Information

Headquarters: 27 Drydock Avenue, Boston, MA 02210
Founded: 2008
Team Size: 700+
Industry: Biotech

What This Means

This funding round demonstrates strong investor confidence in Ginkgo Bioworks's vision and execution. The capital will likely be used to:

Scale Operations: Expand the team and operational capacity
Product Development: Enhance existing products and develop new features
Market Expansion: Enter new markets and strengthen presence in existing ones
Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Ginkgo Bioworks's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $4.9B valuation marks an important milestone for Ginkgo Bioworks, positioning the company among notable players in the Biotech industry.

Looking Ahead

With this new capital, Ginkgo Bioworks is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2024-11-11. For more information about Ginkgo Bioworks, visit their headquarters at 27 Drydock Avenue, Boston, MA 02210.